| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
On arrival at the local emergency department, her temperature was 38.2°C, her pulse was 110 beats/min, her blood pressure was 121/60 mm of Hg, and her oxygen saturation was 80% on room air. She was arousable but oriented only to person. Auscultation of the lungs showed crackles at the left base. The abdomen was soft with normal bowel sounds. There was no lymphadenopathy. Neurologic exam showed no focal deficits. She had leukocytosis (46,800 cells/µL, 19% bands), renal dysfunction (serum creatinine, 1.9 mg/dL), and elevated transaminases (AST, 336 U/L; ALT, 59 U/L). A chest radiograph was interpreted as showing left lower lung atelectasis.
The patient received a diagnosis of community-acquired pneumonia (CAP); a dose of ceftriaxone followed by scheduled ampicillin/sulbactam and levofloxacin were given. She initially defervesced and had improved mentation. By 48 hours after admission, renal failure had worsened (serum creatinine, 4.2 mg/dL). Acidosis and thrombocytopenia (platelets, 54,000 cells/µL) developed. She was transferred to our academic center on hospital Day 3 for further management, where she soon needed intubation and hemodynamic support. Results from the other hospital were reported to include one blood culture bottle growing a gram-positive bacillus interpreted as a contaminant. Lactate dehydrogenase level was elevated (3,296 IU/mL). A moderate number of schistocytes were seen on peripheral smear, the prothrombin time was 1.2 times control, and the partial thromboplastin time was 1.3 times control. Blood cultures on admission to our hospital were negative. With the combination of clinical and laboratory findings, a tentative diagnosis of thrombotic thrombocytopenic purpura was entertained, for which plasmapheresis and plasma exchange were initiated. Several plaques of necrotic skin with surrounding erythema were noted on her chest and upper extremities (Figure 1A
). Several toes were gangrenous (Figure 1B). Histopathologic examination showed dermal necrosis, acute inflammation, and small vessel thrombosis but no visible organisms (Figure 1C, D). Computed tomography of the abdomen showed bilateral renal cortical necrosis (Figure 1F), consistent with a severe, generalized Schwartzman reaction.3 The antibiotic regimen was changed to meropenem and gentamicin when the admission urine culture from the other hospital was reported to be growing > 105 CFU/mL Pseudomonas aeruginosa.
|
). On hospital Day 9, a presumptive identification of Y. pestis was suggested by standard and API biochemical testing and verified by additional biochemical testing. The San Diego County Public Health Laboratory (a Laboratory Response Network Reference Laboratory [LRN]) was immediately notified and identified the isolate as Y. pestis using direct fluorescence antibody testing and polymerase chain reaction testing of the isolate according to federally classified methods of the LRN. Isolates of Y. pestis and cases of plague must be reported within 1 hour to the California Department of Public Health. The evening that the identification was made, a nurse thought that she saw live fleas in the patient’s bed, resulting in moving the patient to another room and sealing off and fumigating the patient’s room. Ultimately these "fleas" were identified as fruit flies.
The patient received 10 days of effective Y. pestis coverage, had an extended hospital stay, remained anuric, elected not to undergo renal replacement therapy, and died from uremia.
Eight days after the confirmation of septicemic plague, the California Department of Public Health Vector-Borne Disease Section carried out a 2-day field study at the case patient’s residence and at two adjacent residences. Live traps for rodents set inside and under the home as well as on the land surrounding all three residences yielded 35 rodents made up of nine species from six genera. Abandoned/inactive ground squirrel burrows along the driveway approaching the patient’s residence provided visible evidence of a plague epizootic. Additionally, the hind leg from a mostly decomposed cottontail rabbit (Sylvilagus spp.) found adjacent to the house and a freshly dead California ground squirrel (S. beecheyi) carcass found on the road 0.6 km north of the home were collected for testing. Blood from the patient’s two dogs, a neighbor’s dog, and from rodents was collected on Nobuto blood-sampling strips and submitted (along with flea pools from the rodents) for serologic testing.
Although serologic results showed no rodents testing positive from the adjacent properties, anecdotal evidence suggested a plague epizootic was heterogeneously distributed throughout the community. From the patient’s property, two of three S. beecheyi tested positive for antibodies to Y. pestis with high titers (1:2,048) suggestive of recent infection. One of the case patient’s two dogs tested positive for antibodies to Y. pestis with a titer of 1:64. None of the other species tested positive for antibodies to plague. However, both the S. beecheyi carcass and rabbit hind leg tested positive by poly-merase chain reaction for Y. pestis. In addition, five flea pools from both serologically positive and negative rodents were positive by polymerase chain reaction for Y. pestis (Table 1). Interestingly (although not unusual), the flea pool from a serologically positive California ground squirrel was negative by polymerase chain reaction, whereas the serologically negative California ground squirrel had a plague-positive flea pool.
|
Yersinia pestis, the etiologic agent of plague, belongs to the Enterobacteriaceae family, with the potential for microbiological confusion leading to diagnostic delay as seen in this case. Growth on media is slow, often requiring 48 hours on enriched media, although experienced microbiologists can distinguish suggestive colony morphology earlier.2 Although Y. pestis is readily suspected by standard automated biochemical strip testing, suspected isolates must be reported to and confirmed by a regional health authority.2
This patient’s exposure is consistent with the epidemiology and ecology of plague. In vivo Y. pestis proliferates rapidly, with the potential of fulminating into the septicemic form of plague associated with high-grade bacteremia, which allows for visualization of bacteria on routine Wright-Giemsa–stained peripheral blood smear, as seen in this case. The high-grade bacteremia was responsible for the bilateral renal cortical necrosis caused by a generalized Schwartzmann reaction.3 Septicemic plague can occur without any obvious painful lymphadenopathy (bubo). Hematogenous dissemination to the lungs leads to pneumonic plague, which has the potential to be transmitted person-to-person through aerosolization.7
Plague has been classified as a bioterrorism disease because of its potential for aerosolization to disperse to large populations with the potential for subsequent person-to-person spread.6 Although the incidence of plague is highest in countries of the developing world, such as in Tanzania and Madagascar, the western United States is well known to be endemic for Y. pestis. Large-scale panic in response to mere possibility of plague, as illustrated in the globally reported but unconfirmed pseudo-epidemic of plague in India in the 1990s,8–10 illustrates the potential of such diseases for causing serious social disruption. Despite the potential for human-to-human spread of plague from patients with pneumonic plague, the last documented case of human-to-human plague transmission in the United States was in 1924,7,11 although this mode of transmission still occurs in endemic regions in less-developed countries.12
Among the general population, there is substantial fear of plague and diseases caused by other class A bioterrorism agents (anthrax, tularemia, botulinum toxin, smallpox, viral hemorrhagic fevers).13 Any suggestion of a potential bioterrorism event is likely to lead to substantial social disruption. For this reason, the federal government has devoted substantial resources for bioterrorism preparedness. A central feature of comprehensive preparedness for a bioterrorist event is early detection and diagnosis, including the clinical recognition of specific diseases and syndromes of such diseases at community-based sentinels, in particular hospitals. Although a physician’s ability to recognize these diseases has been shown to be limited,5 having an adequately functioning clinical microbiology laboratory with appropriately trained microbiology technologists is critical to any sentinel system.14,15 As a number of recent authors have pointed out, the current era of health care expenditure cost cutting and clinical microbiology laboratory outsourcing places the maintenance of basic and rapidly responsive clinical microbiology diagnostic expertise at risk.16,17
Here we present a case of primary septicemic plague, complicated by pulmonary involvement, in a 79-year-old woman who acquired the disease in a known plague-endemic region in California. A number of issues confused the clinical picture, including the initial misidentification of a positive blood culture by a laboratory technologist working in a primarily automated all-in-one community hospital laboratory. This case highlights the potential for poor general community capacity for detecting infectious diseases of bioterrorism potential, even in a known endemic region.
Received March 11, 2008. Accepted for publication March 17, 2008.
Acknowledgments: The authors thank Peter Fedullo and members of the UCSD Medical Center pulmonary and critical care team, Ravindra Mehta and Mita Shah, of the Division of Nephrology, William Read, Thomas Kipps, Dan Tong, and the UCSD Medical Center Department of Medicine housestaff, clinical fellows, and hospital staff for excellent contributions to the care of this patient; Chris Peter and the San Diego County Public Health Services for prompt diagnostic testing; Charles Smith, Curtis Fritz, Jim Tucker, and Tina Feiszli for field and technical support; the California Department of Public Health Microbial Diseases Laboratory for diagnostic animal and arthropod testing, and Bruno Chomel of the UC Davis School of Veterinary Medicine for Nobuto testing.
* Address correspondence to Joseph M. Vinetz, Division of Infectious Diseases, Department of Medicine, University of California, San Diego School of Medicine, 9500 Gilman Drive, 0741, George Palade Laboratories, Room 125, La Jolla, CA 92093. E-mail: jvinetz{at}ucsd.edu 
Authors’ addresses: David Margolis, Sharon Reed, Terrence O’Grady, and Joseph Vinetz, Divisions of Infectious Diseases and Dermatology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla, California. Joseph Burns, California Department of Public Health, Vector-Borne Disease Section, Ontario, California. Michele Ginsberg, San Diego Health Department, San Diego, California
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
